Introduction
============

Neurofibromas typically present most commonly as a cutaneous nodule, less often in a peripheral nerve, occasionally in spinal roots, and multiple neurofibromas are typically associated with neurofibromatosis (NF) 1.^[@B1]--[@B3]^ Histologically, neurofibromas are composed of neoplastic Schwann cells, fibroblasts, and perineurial cells (perineurial-like cells),^[@B2],[@B4],[@B5]^ which in a small number of cases, make it difficult to determine the differential diagnosis from schwannomas.^[@B2],[@B6],[@B7]^ An intramedullary spinal neurofibroma is very rare,^[@B8]--[@B16]^ and to the best of our knowledge, there are no reports of intramedullary neurofibromas in thoracic spinal cord, and moreover, no reports have clearly shown immunohistochemical findings. This report presents a large intramedullary neurofibroma of the thoracic spinal cord and we particularly show the histopathological findings of the tumor, especially immunohistochemical findings of S-100 protein and CD34.

Case Report
===========

A 52-year-old man presenting with a 2-year history of progressive gait disturbance was referred to our hospital. He had neither a past history of NF1 nor any particular disease. Neurological examinations demonstrated complete motor and sensory deficit of his legs with bladder and bowel disturbance. Magnetic resonance (MR) imaging of the thoracic spine demonstrated the intramedullary lesion as a hyperintense mass on T~1~- and T~2~-weighted images between T4 and T5 levels. After gadolinium injection, homogeneous enhancement of the intramedullary lesion was visualized ([Fig. 1A, B](#F1){ref-type="fig"}). Our preoperative diagnosis was ependymoma. The patient underwent surgery in the prone position. A T3--T6 laminectomy was performed to expose the lesion. Following dural opening, we found spinal cord swelling with a thick arachnoid membrane and thin pia mater ([Fig. 2A](#F2){ref-type="fig"}). We confirmed that the tumor was intramedullary. A midline myelotomy was carried out and a grayish tumor immediately appeared ([Fig. 2B](#F2){ref-type="fig"}). The tumor was sharply circumscribed and could be resected easily. During resection of the tumor, we found the posterior spinal root adhered to the dorsal part of tumor, and cut it. We performed total resection of the tumor with the proximal part of the posterior spinal root.

The grayish tumor had a firm consistency and homogeneous cut surface. Microscopically, in some parts of the tumor, tumor cells were composed of interlacing bundles of fibroblast-like cells with abundant collagen ([Fig. 3A](#F3){ref-type="fig"}). These findings resembled a fibrous meningioma; however, neither whorl formation nor psammoma bodies could be seen. In other parts of the tumor, the tumor was characterized by high cellularity with spindle-shaped cells ([Fig. 3B](#F3){ref-type="fig"}). These findings resembled a cellular schwannoma; however, no typical palisading could be seen. Neither mitosis nor nectotic foci were identified in the tumor. Immunohistochemical staining for S-100 protein showed that the tumor cells were partially positive; however, most of fibrous areas with fibroblast-like cells were negative ([Fig. 3C](#F3){ref-type="fig"}). Immunohistochemical staining for CD34 showed that most of the tumor cells were diffusely positive and, especially, fibrous areas with fibroblast-like cells were strongly positive ([Fig. 3D](#F3){ref-type="fig"}). Neurofilament staining showed a few axons in the tumor tissues ([Fig. 3E](#F3){ref-type="fig"}). Most tumor cells were negative for epithelial membrane antigen (EMA) except only limited numbers of EMA-positive cells that was considered to be residual perineurium ([Fig. 3F](#F3){ref-type="fig"}). The tumor cells were negative for glial fibrillary acid protein (GFAP). The Ki-67 labeling index was less than 0.1%. Based on these immunohistochemical findings, especially reactivity for S-100 protein, CD34, and neurofilament, the diagnosis of the intramedullary tumor was neurofibroma, not schwannoma.

His postoperative course was uneventful, and his neurological deficits were unchanged after the operation. Postoperative MR imaging demonstrated no residual tumor.

Discussion
==========

Intramedullary spinal neurofibromas are very rare. In the large Mayo Clinic series reported by Rasmussen et al., no intramedullary lesion was present among 163 cases of spinal neurofibromas.^[@B12]^ Tonnis et al. reported only one intramedullary case among 82 cases of spinal neurofibromas.^[@B15]^ Nittner also found one intramedullary case among their 78 cases of spinal neurofibromas.^[@B10]^ We searched the titles of papers including "intramedullary neurofibromas" using PubMed, and to the best of our knowledge, there are only 6 case reports of intramedullary neurofibromas ([Table 1](#T1){ref-type="table"}).^[@B8],[@B9],[@B11],[@B13],[@B14],[@B16]^ There are no cases in thoracic spinal cord.

It seems to be difficult to identify the exact numbers of intramedullary spinal neurofibromas previously reported from an extensive review of the literature because intramedullary neurofibromas might be confused with intramedullary schwannomas (neurinoma or neurilemoma),^[@B17]--[@B20]^ neuromas,^[@B21]--[@B23]^ and intramedullary aberrant nerve fibers.^[@B23]--[@B25]^

Neurofibromas are composed of a mixture of cell types including Schwann cells, perineurial-like cells, and fibroblasts.^[@B2],[@B4],[@B5]^ To distinguish neurofibromas from schwannomas and neuromas, careful and precise pathological examinations should be performed. Immunohistochemical staining for S-100 protein has been used classically as a marker in the differential diagnosis of neurofibromas from schwannomas;^[@B2],[@B4],[@B5]^ however, occasionally, S-100 protein might not reliably distinguish these tumors,^[@B2],[@B6]^ namely, the immunohistochemical reaction for S-100 protein is positive in both tumors. Usually, the immunoreactivity of S-100 protein is higher in schwannomas than neurofibromas.^[@B2],[@B6],[@B26]^ In our case, tumor cells were partially positive for S-100, which suggested that the tumor might be a neurofibroma rather than a schwannoma.

Recently, the usefulness of immunohistochemical staining for CD34 has been reported to differentiate neurofibromas from schwannomas.^[@B26]^ CD34 was first identified as a marker of hematopoietic progenitor cells, and it is also a marker of nerve sheath cells.^[@B7],[@B26]^ The nature of CD34-positive cells is thought to correspond to that of endoneurial fibroblasts. Neurofibromas are strongly positive for CD34, unlike most schwannomas. In our case, CD34 was diffusely positive for most tumor cells, and was especially strongly positive for fibroblast-like cells. S-100 protein was demonstrated in some parts of tumor cells, and moreover, negative in fibrous areas with fibroblast-like cells. These findings suggested that the tumor was a neurofibroma. Solitary fibrous tumors (SFTs) also should be distinguished from neurofibromas. Although both tumors are positive for CD34, SFT are usually negative for S-100 protein.^[@B27]^ Immunohisto-chemical reactions for S-100 protein suggested this tumor was not a SFT. In addition, neurofibromas grow within and envelop the nerve of origin, and neurofilaments are seen as entrapped nerve remnants in tumors, which are not present in schwannomas and SFT.^[@B2]^ Limited numbers of EMA-positive cells also can be seen as residual perineurium in neurofibromas.^[@B2]^

Various hypotheses have been suggested to explain the origin of intramedullary spinal neurofibromas as follows: (a) aberrant neural crest cells displaced into the spinal cord during embryonic development;^[@B19],[@B28]^ (b) intramedullary perivascular nerve bundles in the spinal cord;^[@B29],[@B30]^(c) aberrant intramedullary nerve fibers;^[@B23],[@B24],[@B25],[@B31]^ (d) posterior roots near the root entry zone and development of tumors in the pia mater;^[@B17],[@B18],[@B20]^ and (e) transformation of pial cells of neuroectodermal origin into Schwann cells.^[@B32]^ In the current case, the tumor was situated at a posterior site in the spinal cord in close proximity to the dorsal root entry zones. The tumor tightly adhered to the dorsal root. It seems likely that the tumor in our case arose from the dorsal root sheath zone and grew into the pia mater considering operative findings. Therefore this tumor might not be "pure" intramedullary neurofibroma in a sense.

![Sagittal (A) and axial (B) T~1~-weighted magnetic resonance (MR) images with gadolinium demonstrating an intramedullary tumor with homogeneous enhancement between T4 and T5 level mimicking an ependymoma.](nmc-54-752-g1){#F1}

![Intraoperative photographs. A: Intraoperative photograph after opening dura showing swollen spinal cord with thick arachnoid membrane. B: Intraoperative photograph after midline myelotomy showing an intramedullary tumor.](nmc-54-752-g2){#F2}

![Histological examination of an intramedullary tumor. A: Photomicrograph showing interlacing bundles of fibroblast-like cells with abundant collagen. HE stain, magnification ×200. B: Photomicrograph showing high cellularity with spindle-shaped cells. HE stain, magnification ×200. C: Immunohistochemical staining for S-100 protein showing that the tumor cells were partially positive; however most of fibrous areas with fibroblast-like cells were negative. Magnification ×200. D: Immunohistochemical staining for CD34 showing that most tumor cells were diffusely positive. Magnification ×200. E: Neurofilament staining showing a few axons in the tumor tissues. Magnification ×200. F: Epithelial membrane antigen (EMA) staining showing that most tumor cells were negative except limited numbers of EMA positive cells. Magnification ×200.](nmc-54-752-g3){#F3}

###### 

Summary of cases of intramedullary neurofibroma

  Case no.   Author (year)                            Age/sex   Symptoms                                      Location           Radiological examination   NF1 or NF2   Pathological examination
  ---------- ---------------------------------------- --------- --------------------------------------------- ------------------ -------------------------- ------------ --------------------------
  1\.        Gelabert et al. (1996)^[@B8]^            50/F      Tetraparesia                                  C2--4              MRI                        None         HE
  2\.        Oka et al. (1992)^[@B11]^                62/F      Paresthesia of hands and feet                 C3--4              CT, MRI                    None         HE, Bodian
  3\.        Sharma V and Newton (1990)^[@B14]^       20/M      Weakness in upper limbs                       C7                 Myelogram, CT              None         HE
  4\.        Gelabert González et al. (1985)^[@B9]^   29/F      Paresthesia of hands                          C2--4              Myelogram, CT              None         HE
  5\.        Sharma R et al. (1984)^[@B13]^           27/M      Weakness in upper and lower limbs             C5--6              Myelogram                  None         HE
  6\.        Young et al. (1983)^[@B16]^              33/F      Paresthesia and weakness in legs              Conus medullaris   Myelogram                  None         HE
  7\.        Present case                             52/M      Parapresia, bladder, and rectal disturbance   T4--5              MRI                        None         HE, S-100, CD34

C: cervical, CT: computed tomography, F: female, HE: hematoxylin and eosin, M: male, MRI: magnetic resonance imaging, NF: neurofibromatosis, T: thoracic.
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